B/Singapore/222/79-1ike influenza viruses isolated from three patients during the winter of 1981 to 1982 and cultured in either embryonated hens' eggs or MDCK cells were studied. Sequence analysis indicated that the haemagglutinin (HA) genes of the six virus preparations contained at least four distinct HA1 sequences which differed by up to six amino acids. Only one pair of viruses had amino acid differences between the egg-and MDCK cell-derived viral subpopulations and this change did not affect a glycosylation site. Mice infected with previously described recombinant vaccinia viruses expressing either the egg-or MDCK cell-derived HA of B/England/222/82 developed neutralizing antibodies against all of the 1982 type B viruses and were protected against intranasal challenge with these viruses. Therefore, in this model system, the minor sequence variation between the HAs of egg-and MDCK cell-derived influenza B/England/222/82 virus had no detectable effect on the induction of crossprotection.
Cross-protection against Microvariants of Influenza Virus
SUMMARY B/Singapore/222/79-1ike influenza viruses isolated from three patients during the winter of 1981 to 1982 and cultured in either embryonated hens' eggs or MDCK cells were studied. Sequence analysis indicated that the haemagglutinin (HA) genes of the six virus preparations contained at least four distinct HA1 sequences which differed by up to six amino acids. Only one pair of viruses had amino acid differences between the egg-and MDCK cell-derived viral subpopulations and this change did not affect a glycosylation site. Mice infected with previously described recombinant vaccinia viruses expressing either the egg-or MDCK cell-derived HA of B/England/222/82 developed neutralizing antibodies against all of the 1982 type B viruses and were protected against intranasal challenge with these viruses. Therefore, in this model system, the minor sequence variation between the HAs of egg-and MDCK cell-derived influenza B/England/222/82 virus had no detectable effect on the induction of crossprotection.
In order to compare the immune response induced by influenza virus haemagglutinins (HAs) differing by a single amino acid, we cloned the genes for a pair of such HA variants and expressed them in vaccinia virus (Rota et al., 1987) . These variant HA genes were previously described as being present in either egg-derived or MDCK cell-derived subpopulations of a single isolate of influenza B/England/222/82 virus (B/Eng) (Schild et al., 1983) . The single amino acid difference between the HAs was found at residue 198, which is near the receptor-binding site on the distal tip of the HA1 portion of the molecule. This change resulted in the loss of a specific N-linked glycosylation site that was present on the HA of virus from the MDCK cellderived subpopulation (Robertson et al., 1985) . Our previous work has shown that mice vaccinated with the recombinant vaccinia viruses expressing either of the variant HAs were equivalently protected from infection after challenge by each of the B/Eng virus subpopulations (Rota et al., 1987) .
Influenza viruses isolated during the course of outbreaks are not antigenically or genetically homogeneous (Webster & Berton, 1981 ; Kendal et al., 1978) . Since viruses for use in inactivated influenza vaccines are currently cultivated in hens' eggs, it is important to determine whether adaptation to growth in eggs would reduce the vaccine efficacy of a virus if it differed from the viruses associated with influenza outbreaks. To address this question, we further tested our recombinant vaccinia virus vaccines against additional field isolates of influenza B.
We received from the Influenza Center of the Baylor College of Medicine (Houston, Texas, U.S.A.) three pairs of influenza viruses that had been isolated during a period of epidemic activity in Houston in 1982. Viruses were isolated from the original clinical material and subsequently passaged exclusively in both embryonated eggs and MDCK cells. The viruses were identified as influenza B after one or two passages (Table 1) . Three pairs of isolates designated 0000-8759 © 1989 SGM Short communication B/3703, B/3775 and B/3789, were selected at random from specimens received during the influenza outbreak. Each of the viruses was re-isolated in their respective culture system and analysed using haemagglutination inhibition (HI) assays with post-infection ferret sera (Table  1 ). The results indicated that all of the isolates were more antigenically related to the B/Singapore/222/79 (B/Sing) reference strain than to the later isolate, B/USSR/100/83 (B/USSR), which is a reference strain for variants that caused major epidemics in 1983 to 1984. Ferret antiserum detected only minor differences in antigenicity between the egg-or MDCK cell-derived subpopulations of each of the isolates tested. Therefore, the Houston isolates, like B/Eng (Harmon et al., 1988) , were antigenically representative of influenza B viruses circulating during the 1982 to 1983 influenza season and closely related to the vaccine strain (B/Sing) in use at that time.
To determine the sequence of the HA genes from these Houston isolates, RNA was prepared (Bean et al., 1980) from virus grown in both eggs and MDCK cells and sequenced as previously described (Robertson et al., 1985) using the primer series described by Rota et aL (1987) . Table 2 shows the amino acid changes in the HA1 region of the HAs from the Houston isolates compared to the sequence of the reference strain, B/Sing, and the two variant HAs from the B/Eng subpopulations. The Houston isolates differed from each other by three to four amino acid residues. This is consistent with sequence analysis of HA genes from influenza type A (H3N2) viruses isolated from different individuals during an epidemic where five to six amino acid changes were found (Katz et al., 1987) . Only one pair of isolates, B/3775, had amino acid sequence differences between the egg-and MDCK cell-derived RNA. These changes occurred at amino acid residues 196 and 198. As a group, the Houston viruses consistently differed from B/Eng and B/Sing at positions 196 and 197.
Alignments of influenza type A and B HA gene sequences (Krystal et al., 1982; Verhoeyen et al., 1983) have indicated that this region of the influenza B HA is located near the receptorbinding pocket at the distal tip of the HA molecule in an area of the molecule that is analogous to antigenic site B of the influenza type A (H3N2) HA (Wiley et al., 1981) . Sequence analysis of the HAs from different strains of influenza B virus have confirmed that multiple amino acid changes are common at this site (Krystal et al., 1982; Verhoeyen et al., 1983 ; Yamashita et aL, 1988 ) which may represent a major antigenic region on the influenza B HA (Berton et al., 1984; Berton & Webster, 1985) . Some of the Houston isolates also have changes at amino acid residues 68, 69, 82 and 118. Although these changes occur in regions of the HA that are analogous to antigenic sites previously mapped on the H3N2 HA (site E: 68, 69; site A: 118), these amino acids have not previously been proposed to be in antigenic regions of the type B HA (Krystal et al., 1982; Verhoeyen et al., 1983) . Only the change at residue 68 (Gly~Ala) is found in the HA of later, epidemiologically significant strains of influenza B (Yamashita et al., 1988) .
No amino acid changes were found that would affect the potential glycosylation of the HA molecules from the Houston isolates. By direct RNA sequencing, Robertson et al. (1985) found a glycosylation site present at residues 196 to 198 on the HAs of B/Eng and several other influenza B viruses isolated in 1982 in MDCK cells. This glycosylation site was not found in isolates from the same specimens that had been passaged in eggs. Our results appear to be at variance with those cited above. However, analysis of individual HA cDNA clones prepared from B/Eng MDCK cell-derived RNA indicated that this viral subpopulation contains viruses with a variety of different HA sequences some of which lack the additional glycosylation signal (Rota et al., 1987) . The heterogeneity of this subpopulation was also confirmed by immunoelectron microscopy (Patterson & Oxford, 1986) . It is likely that the relative amounts of the different variants will vary within a single subpopulation and the sequence determined from viral RNA will represent that of the most abundant variant. The lack of differences between the egg-and MDCK celt-derived HA genes of two of the three Houston isolates is consistent with results described for some type A (H3N2) influenza viruses where host cell-associated amino acid differences in the HA have not always been detected (Katz et al., 1987) .
To test for cross-protection against the set of influenza type B variants from Houston, mice were vaccinated with the recombinant vaccinia viruses expressing either the egg-or MDCK cell-derived HA of B/Eng. By using recombinant vaccinia viruses, we were able to vaccinate the (M) . Passage level at time of virus identification is shown. For some specimens, two passages were needed to obtain a sufficient virus titre for identification.
t Virus in egg harvests was identified by HI using ferret polyclonal antiserum. Virus in MDCK cell harvests was identified by enzyme immunoassay with polyclonal sera.
Viruses were re-isolated and tested at the passage level shown. § HI tests were performed using post-infection ferret serum according to the method described by Dowdle et al. (1979) . mice with a defined, homogeneous preparation of influenza virus HA. Serum samples from the mice were able to neutralize all of the Houston isolates, although in some cases the neutralization titres were much lower than those against the B/Eng viruses (Table 3) . Sera from mice vaccinated with the vaccinia virus expressing the MDCK cell-derived HA of B/Eng had a lower homologous titre, but were more broadly reactive than sera from mice vaccinated with the vaccinia virus expressing the egg-derived B/Eng HA. These results are similar to those reported for influenza A (H1N1) viruses where it has been shown that polyclonal antiserum against the Short communication (Rota et al., 1987) .
t Serum samples were obtained from the vaccinated mice at 30 days post-vaccination. Neutralization tests were performed using the protocol described by Anderson et aL (1986) modified for use with influenza virus (Harmon et al., 1988) . Table shows mean titre from at least six mice.
:~ For challenge experiments, mice vaccinated with the recombinant vaccinia viruses or wild-type vaccinia virus were given 106 TCID50 of challenge virus by the intranasal route 30 days after vaccination. Lung homogenates, prepared 3 days after infection, were tested for influenza B antigen using a capture time-resolved tluoroimmunoassay (TR-FIA) (Walls et al., 1986) . Numbers in the table indicate the percentage reduction of influenza virus antigen detected in lung homogenates from mice vaccinated with the recombinant vaccinia viruses compared with mice vaccinated with wild-type vaccinia virus. The amount of influenza nucleocapsid antigen present in the lung as determined by TR-FIA has been compared to data obtained from plaque assay on MDCK cell monolayers and a good correlation between TR-FIA c.p.m, and infectious virus was observed (Rota et al., 1987, and unpublished observations) .
§ ND, These viruses were omitted because they showed poor mouse infectivity.
MDCK cell-derived HA does not distinguish between variant strains while antiserum against egg-derived HA showed much more variability in reactivity (Oxford et al., 1987) . In spite of the differences in neutralizing antibody titres, however, both recombinant vaccinia vaccines gave equivalent amounts of protection against intranasal challenge by two of the Houston isolates (Table 3) . The results of this study indicate that vaccination of mice with the HA of egg-derived B/Eng virus was able to induce an immune response that can protect against infection with influenza B isolates exhibiting minor sequence differences. In this case, the vaccine was able to protect against viruses with as many as six amino acid changes in HA1. Although amino acid changes occurred in one or more of the proposed neutralization epitopes on the HAs of the challenge viruses, these viruses are unable to evade the protective immunity induced by the vaccine. Presumably, this is because other epitopes on the expressed HA were also responsible for inducing protective immunity. These results are consistent with the findings of a recent study which showed that ferrets infected with either egg-or MDCK cell-derived influenza A (H3N2) virus were protected against subsequent challenge by virus derived from either host cell type (Katz et al., 1987) . Also, a study of human vaccine recipients indicated that persons receiving the B/Sing vaccine generated neutralizing antibody responses against both egg-and MDCK cell-derived subpopulations of B/Eng which differ from B/Sing by four or five amino acids in HAl (Harmon et al., 1988) .
With the caveat that extrapolations from animal studies to human experiences may not always be valid, it seems unlikely that influenza vaccines are inherently unable to protect against other microvariant viruses in circulation that differ from the vaccine strain by only a few amino acids. Further studies are now in progress using the model system described above to evaluate the extent of variation that can occur in the HA before vaccine-induced protection is impaired.
